These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8788167)

  • 1. Retroviral vector sequences may interact with some internal promoters and influence expression.
    Wu X; Holschen J; Kennedy SC; Ponder KP
    Hum Gene Ther; 1996 Jan; 7(2):159-71. PubMed ID: 8788167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction.
    Rettinger SD; Kennedy SC; Wu X; Saylors RL; Hafenrichter DG; Flye MW; Ponder KP
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1460-4. PubMed ID: 8108431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
    Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
    Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo.
    Okuyama T; Huber RM; Bowling W; Pearline R; Kennedy SC; Flye MW; Ponder KP
    Hum Gene Ther; 1996 Mar; 7(5):637-45. PubMed ID: 8845389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter.
    Vile RG; Diaz RM; Miller N; Mitchell S; Tuszyanski A; Russell SJ
    Virology; 1995 Dec; 214(1):307-13. PubMed ID: 8525635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes.
    Hafenrichter DG; Wu X; Rettinger SD; Kennedy SC; Flye MW; Ponder KP
    Blood; 1994 Nov; 84(10):3394-404. PubMed ID: 7949094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
    Couture LA; Mullen CA; Morgan RA
    Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D; Elliott JF; Chang LJ
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution analysis of cytosine methylation in the 5ĺong terminal repeat of retroviral vectors.
    Wang L; Robbins PB; Carbonaro DA; Kohn DB
    Hum Gene Ther; 1998 Nov; 9(16):2321-30. PubMed ID: 9829531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral-mediated gene expression in human myelomonocytic cells: a comparison of hematopoietic cell promoters to viral promoters.
    Malik P; Krall WJ; Yu XJ; Zhou C; Kohn DB
    Blood; 1995 Oct; 86(8):2993-3005. PubMed ID: 7579392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.
    Guo ZS; Wang LH; Eisensmith RC; Woo SL
    Gene Ther; 1996 Sep; 3(9):802-10. PubMed ID: 8875229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.
    Freas-Lutz DL; Correll PH; Dougherty SF; Xu L; Pluznik DH; Karlsson S
    Exp Hematol; 1994 Aug; 22(9):857-65. PubMed ID: 8062885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral vector design for long-term expression in murine hematopoietic cells in vivo.
    Correll PH; Colilla S; Karlsson S
    Blood; 1994 Sep; 84(6):1812-22. PubMed ID: 8080986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral vector gene expression in F9 embryonal carcinoma cells.
    Linney E; Neill SD; Prestridge DS
    J Virol; 1987 Oct; 61(10):3248-53. PubMed ID: 3041045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of phosphoenolpyruvate carboxykinase (PEPCK) chimeras in renal epithelial cells. Retention of appropriate physiological responsiveness using enhancerless retroviral vectors.
    Pollock AS; Lovett DH
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):725-32. PubMed ID: 1377912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
    Weber EL; Cannon PM
    Hum Gene Ther; 2007 Sep; 18(9):849-60. PubMed ID: 17767401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene.
    Flasshove M; Bardenheuer W; Schneider A; Hirsch G; Bach P; Bury C; Moritz T; Seeber S; Opalka B
    J Cancer Res Clin Oncol; 2000 Jul; 126(7):391-9. PubMed ID: 10929761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector.
    Moore KA; Scarpa M; Kooyer S; Utter A; Caskey CT; Belmont JW
    Hum Gene Ther; 1991; 2(4):307-15. PubMed ID: 1838933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
    Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
    J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.